SIS
KURA icon

Strategic Investment Solutions’s Kura Oncology KURA Stock Holding History

Strategic Investment Solutions’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$660 – 647
2025
Q1 		$660 Hold
100
– – ﹤0.01% 561
2024
Q4 		$871 Hold
100
– – ﹤0.01% 568
2024
Q3 		$1.95K Hold
100
– – ﹤0.01% 499
2024
Q2 		$2.08K Buy
+100
New +$2.06K ﹤0.01% 493

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Strategic Investment Solutions's KURA Position: Q2 2025 in Review

Strategic Investment Solutions sold out of Kura Oncology (KURA) in Q2 2025, closing a stake of 100 shares — an estimated $660 sold.

Strategic Investment Solutions first reported a position in KURA in Q2 2024 and held it in 4 quarters. The position peaked at $2.08K in Q2 2024. 182 funds tracked by Wall St. Rank hold KURA as of Q2 2025.

  • Strategic Investment Solutions reported no remaining Kura Oncology position as of Q2 2025 after selling out during the quarter.
  • Strategic Investment Solutions sold 100 Kura Oncology shares in Q2 2025, an estimated $660.
  • Strategic Investment Solutions first reported a position in Kura Oncology in Q2 2024 and held it in 4 quarters.
  • Strategic Investment Solutions's Kura Oncology position peaked at $2.08K in Q2 2024.
  • 182 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2025.

Based on Strategic Investment Solutions's 13F filing for Q2 2025, filed 16 Jul 2025.